Feasibility of novel adult tuberculosis vaccination in South Africa: a cost-effectiveness and budget impact analysis.Friday, August 9, 2024Availability, Economic impact/cost-effectivenss, Implementation strategies and feasibilityRead More
Potential impact of tuberculosis vaccines in China, South Africa, and IndiaFriday, August 9, 2024Availability, Epidemiological impactRead More
Impact of targeted tuberculosis vaccination among a mining population in South Africa: A model based studyFriday, August 9, 2024Availability, Epidemiological impactRead More
Potential impact of spatially targeted adult tuberculosis vaccine in Gujarat, IndiaFriday, August 9, 2024Availability, Epidemiological impactRead More
The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug resistant tuberculosis in India and ChinaFriday, August 9, 2024Availability, Economic impact/cost-effectivenss, Epidemiological impactRead More
Making wider use of the world’s most widely used vaccine: Bacille Calmette-Guerin revaccination reconsideredFriday, August 9, 2024Availability, Economic impact/cost-effectivenss, Epidemiological impactRead More
TB case-finding in the context of future vaccinesFriday, August 9, 2024Availability, Economic impact/cost-effectivenssRead More
Population-level health and economic impacts of introducing Vaccae vaccination in China: a modelling studyFriday, August 9, 2024Availability, Economic impact/cost-effectivenss, Epidemiological impactRead More
Is neglect of self-clearance biasing TB vaccine impact estimates?Friday, August 9, 2024Availability, Epidemiological impactRead More
The full value of vaccine assessments concept—current opportunities and recommendationsFriday, August 9, 2024Availability, Policy and frameworksRead More
